THURSDAY, Nov. 4, 2021 (HealthDay News) — Here’s some comforting news for people who struggle with inflammatory bowel disease and worry that the immune-suppressing drugs they must take might blunt their response to COVID-19 vaccines: New research finds vaccination triggers a strong immune reaction in these patients. “At eight weeks,Continue Reading

THURSDAY, Oct. 28, 2021 (HealthDay News) — Younger patients with advanced colon cancer don’t live longer than older patients, but it’s unclear why, researchers say. The authors of the new study said they were surprised by the findings, which come as colon cancer rates are on the rise among youngContinue Reading

TUESDAY, Oct. 26, 2021 (HealthDay News) — Antidepressants called selective serotonin reuptake inhibitors (SSRIs) are a mainstay of depression treatment, but a new study warns that taking common painkillers alongside SSRIs may raise the chances for intestinal bleeding. In a review of 10 published studies involving 6,000 patients, researchers foundContinue Reading

TUESDAY, Oct. 19, 2021 (HealthDay News) — While they’re helping to ease reflux, some heartburn drugs may also be reducing the severity of gum disease, new research suggests. For the study, researchers assessed probing depth in the gums (the gap between teeth and gums) in more than 1,000 patients withContinue Reading

TUESDAY, Oct. 12, 2021 (HealthDay News) — Patients who undergo surgery for certain types of cancer may have better short-term survival if they receive a particular anti-nausea drug, a preliminary study suggests. Among more than 74,000 patients who had cancer surgery, researchers found that those who received the drug —Continue Reading

MONDAY, Oct. 4, 2021 (HealthDay News) — Colon cancer numbers dropped dramatically during the COVID-19 pandemic, but that doesn’t mean fewer people have the disease. In Spain, researchers discovered a more than 40% decline in colon cancer diagnoses, leading experts to worry about the ramifications. “These are very worrying findingsContinue Reading

WEDNESDAY, Sept. 29, 2021 (HealthDay News) — A drug previously approved for multiple sclerosis also can treat inflammatory bowel disease in some patients, a new clinical trial reports. The medication, ozanimod (Zeposia), proved effective in helping patients with ulcerative colitis, sending many into full remission, according to results being publishedContinue Reading

MONDAY, Sept. 20, 2021 (HealthDay News) — After routine surgery, a “virtual” follow-up visit might be just as good as a traditional office appointment, a new study suggests. Researchers found that surgery patients who had video follow-up appointments were just as satisfied with their care as those who made aContinue Reading

WEDNESDAY, Sept. 15, 2021 (HealthDay News) — Colon cancer risk runs in families, and it’s not just a parent or sibling having had the disease that should concern you. If you have a second- or third-degree relative who had colon cancer at an early age, your odds of having theContinue Reading

WEDNESDAY, Sept. 1, 2021 (HealthDay News) — COVID-19 vaccines trigger antibody production in most people who have weakened immune systems, but a new study reveals that their responses are weaker than in healthy people. “Some of our patients have been hesitant about getting vaccinated, which is unfortunate because they areContinue Reading

TUESDAY, Aug. 10, 2021 (HealthDay News) — Colonoscopy screening can help prevent colon cancer by allowing doctors to find and remove potentially pre-cancerous growths called polyps. But if they fail to get the whole growth, the odds of a recurrence are high, a new study shows. The likelihood that itContinue Reading